0001708138-20-000026.txt : 20200403
0001708138-20-000026.hdr.sgml : 20200403
20200403160814
ACCESSION NUMBER: 0001708138-20-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200401
FILED AS OF DATE: 20200403
DATE AS OF CHANGE: 20200403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAROSA JOSEPH J
CENTRAL INDEX KEY: 0001238303
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20773398
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-04-01
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001238303
LAROSA JOSEPH J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP General Counsel and Secret
Common Stock
2020-04-01
4
M
0
5000
59.2
A
19438
D
Common Stock
2020-04-01
4
F
0
2757
488.22
D
16681
D
Common Stock
2020-04-01
4
M
0
5000
59.2
A
21681
D
Common Stock
2020-04-01
4
F
0
2757
488.22
D
18924
D
Common Stock
2020-04-01
4
M
0
5000
59.2
A
23924
D
Common Stock
2020-04-01
4
F
0
2689
488.22
D
21235
D
Common Stock
2020-04-02
4
S
0
192
484.58
D
21043
D
Common Stock
2020-04-02
4
S
0
441
485.65
D
20602
D
Common Stock
2020-04-02
4
S
0
485
486.61
D
20117
D
Common Stock
2020-04-02
4
S
0
470
487.71
D
19647
D
Common Stock
2020-04-02
4
S
0
1626
488.26
D
18021
D
Common Stock
2020-04-02
4
S
0
734
489.72
D
17287
D
Common Stock
2020-04-02
4
S
0
484
490.32
D
16803
D
Common Stock
2020-04-02
4
S
0
450
491.42
D
16353
D
Common Stock
2020-04-02
4
S
0
521
492.62
D
15832
D
Common Stock
2020-04-02
4
S
0
652
493.35
D
15180
D
Common Stock
2020-04-02
4
S
0
111
494.36
D
15069
D
Common Stock
2020-04-02
4
S
0
321
495.19
D
14748
D
Common Stock
2020-04-02
4
S
0
210
496.5
D
14538
D
Common Stock
2020-04-02
4
S
0
100
497.32
D
14438
D
Common Stock
255
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
59.2
2020-04-01
4
M
0
5000
0.0
D
2021-09-01
Common Stock
5000
49933
D
Non-Qualified Stock Option (right to buy)
59.2
2020-04-01
4
M
0
5000
0.0
D
2021-09-01
Common Stock
5000
44933
D
Non-Qualified Stock Option (right to buy)
59.2
2020-04-01
4
M
0
5000
0.0
D
2021-09-01
Common Stock
5000
39933
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 192 shares of Company stock on April 2, 2020 at prices ranging from $484.12 to $484.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 441 shares of Company stock on April 2, 2020 at prices ranging from $485.01 to $485.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 485 shares of Company stock on April 2, 2020 at prices ranging from $486.15 to $486.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 470 shares of Company stock on April 2, 2020 at prices ranging from $487.32 to $487.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 1,626 shares of Company stock on April 2, 2020 at prices ranging from $488.00 to $488.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 734 shares of Company stock on April 2, 2020 at prices ranging from $489.31 to $489.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 484 shares of Company stock on April 2, 2020 at prices ranging from $490.11 to $490.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 450 shares of Company stock on April 2, 2020 at prices ranging from $491.13 to $491.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 521 shares of Company stock on April 2, 2020 at prices ranging from $492.22 to $492.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 652 shares of Company stock on April 2, 2020 at prices ranging from $493.01 to $493.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 111 shares of Company stock on April 2, 2020 at prices ranging from $494.29 to $494.38. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 321 shares of Company stock on April 2, 2020 at prices ranging from $495.09 to $495.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 210 shares of Company stock on April 2, 2020 at prices ranging from $496.37 to $496.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
/s/**Joseph J. LaRosa
2020-04-03